CN214966371U - Device for treating lymphatic vessel deformity by objectively and quantitatively injecting medicine dose - Google Patents

Device for treating lymphatic vessel deformity by objectively and quantitatively injecting medicine dose Download PDF

Info

Publication number
CN214966371U
CN214966371U CN202120186479.8U CN202120186479U CN214966371U CN 214966371 U CN214966371 U CN 214966371U CN 202120186479 U CN202120186479 U CN 202120186479U CN 214966371 U CN214966371 U CN 214966371U
Authority
CN
China
Prior art keywords
pipe
medicine
injection
way pipe
liquid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202120186479.8U
Other languages
Chinese (zh)
Inventor
刘潜
谢明峰
刘海金
刘建平
曾林山
曾勇
徐仙贇
陈枫
黄海金
彭威
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gannan Medical University
Original Assignee
Gannan Medical University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gannan Medical University filed Critical Gannan Medical University
Priority to CN202120186479.8U priority Critical patent/CN214966371U/en
Application granted granted Critical
Publication of CN214966371U publication Critical patent/CN214966371U/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

The utility model discloses a device for objectively and quantitatively injecting medicine dosage to treat lymphatic vessel malformation, which comprises an injection tube, a syringe connected to the liquid injection end of the injection tube and a scalp needle connected to the liquid outlet end of the injection tube, wherein the injection tube is connected with a branch tube, the branch tube is connected with a pressure gauge, a waterproof breathable film is arranged in the radial section of the branch tube, the waterproof breathable film can block the circulation of medicine, and the waterproof breathable film has elasticity and can realize pressure transmission to one side after the other side is pressurized; the utility model discloses be provided with waterproof ventilated membrane on annotating the pipeline of liquid union coupling manometer, can prevent the medicine flow direction manometer to can rely on the elasticity that waterproof ventilated membrane itself has to realize the pressure intercommunication of its both sides, thereby can be on showing injection pressure's basis, avoid the medicine to get into the inaccurate or medicine pollution of measurement that the medicine loss that the manometer caused arouses.

Description

Device for treating lymphatic vessel deformity by objectively and quantitatively injecting medicine dose
Technical Field
The utility model relates to a medical treatment injection device field especially relates to a device that is used for objective ration injection medicine dose to treat lymphatic vessel deformity.
Background
Lymphangioma (LM), which has been known as "lymphangioma," is a common congenital vascular malformation disease. LM can be classified into three types, i.e., macrocyst type, microcapsule type and mixed type, according to the size of the lymphatic tumor cavity. The macrocapsular LM consists of 1 or more tumor cavities with a volume of 2cm or more (known as cyst-type or cystic edema), while the microcapsule LM consists of more tumor cavities with a volume of 2cm or less (known as capillary and sponge), both of which are known as mixed LM. The incidence rate of LM is 1/4000-1/2000, and no sex and ethnic difference is found. The disease usually occurs before the age of 2 years, and about 50% of patients are born with the disease. LM can occur in any body part with lymphatic ductal network, with about 75% of lesions occurring in the head, neck, and next to the armpits, mediastinum, and limbs. LM is considered a benign lesion of the lymphatic system, growing slowly with little natural regression. But often suddenly increases after suffering trauma, infection, and the occurrence of intracapsular hemorrhage or improper treatment. If LM grows in a special position, it may cause disfigurement, deformity, and stress of important organs to cause dysfunction, resulting in long-term sequelae.
At present, LM has various treatment methods, and the interventional injection treatment is used as a novel treatment means and has been widely applied to clinic due to the characteristics of local administration, good effect, little side effect and the like. Chinese patent No. CN203647805U discloses an injector, which comprises an injection mechanism and a hose connected to the injection mechanism, wherein a pressure gauge is disposed on the hose for displaying the pressure of the injection mechanism for injecting the medicine, but the pressure gauge is directly connected to the hose, the medicine can enter the pressure gauge, which results in inaccurate display of the injection amount of the medicine and possible contamination to the medicine.
SUMMERY OF THE UTILITY MODEL
The utility model aims at providing a device that is used for objective ration injection medicine dose treatment lymphatic vessel deformity, with the problem that solves above-mentioned prior art existence, be provided with waterproof ventilated membrane on annotating the pipeline of liquid union coupling manometer, can prevent medicine flow direction manometer, and can rely on the elasticity that waterproof ventilated membrane itself has to realize the pressure intercommunication of its both sides, thereby can be on the basis that shows injection pressure, avoid the medicine to get into the inaccurate or medicine pollution of measurement that the medicine loss that the manometer caused.
In order to achieve the above object, the utility model provides a following scheme:
the utility model provides a device for being used for objective ration injection medicine dosage treatment lymph duct deformity, including annotating the liquid pipe, connecting annotate the liquid pipe and annotate a syringe of liquid end and connect and be in annotate the scalp acupuncture that the liquid end was gone out to the liquid pipe, annotate and be connected with a bleeder on the liquid pipe, a bleeder is connected with the manometer, be provided with waterproof ventilated membrane in the radial cross-section of bleeder, waterproof ventilated membrane can block the medicine circulation, just waterproof ventilated membrane has elasticity, can bulge after one side receives pressure and realize pressure transmission to the opposite side.
Preferably, the first branch pipe comprises two pipe joints which are arranged oppositely, and the waterproof breathable film is arranged between the two pipe joints.
Preferably, the waterproof and breathable film is an e-PTFE film.
Preferably, the liquid injection pipe is provided with a first three-way pipe, and the first three-way pipe is connected with the first branch pipe.
Preferably, the first three-way pipe is a regular three-way pipe, and the first injector and the pressure gauge are respectively connected to two ends of a main pipe of the regular three-way pipe.
Preferably, a second branch pipe is arranged on a pipeline between the first injector and the first three-way pipe, and the second branch pipe is connected with the second injector.
Preferably, a second three-way pipe is arranged between the first injector and the first three-way pipe, and the second three-way pipe is connected with the second branch pipe.
Preferably, a first check valve is arranged between the first injector and the first three-way pipe, and a second check valve is arranged between the second injector and the second three-way pipe.
The utility model discloses for prior art gain following technological effect:
(1) the utility model is provided with the waterproof breathable film on the pipeline of the liquid injection pipe connected with the pressure gauge, which can prevent the medicine from flowing to the pressure gauge and realize the pressure intercommunication of the two sides thereof by the elasticity of the waterproof breathable film, thereby avoiding the inaccurate metering or the medicine pollution caused by the medicine loss caused by the medicine entering the pressure gauge on the basis of displaying the injection pressure;
(2) the utility model discloses a tumor chamber that manometer, syringe and scalp acupuncture pricked can be linked together through the setting of bleeder line one number to can rely on the manometer to show the pressure in the tumor chamber, can show pressure P0 after carrying out physiological saline and wash, show pressure after injecting the medicine to be P1, utilize the two to obtain delta P by subtracting, can control the injection medicine in every tumor chamber to be relative quantitative value through controlling delta P;
(3) the first three-way pipe of the utility model adopts a three-way pipe, and the injector and the pressure gauge are respectively connected with two ends of the main pipe of the three-way pipe, so that the medicine or the physiological saline can directly flow to the pressure gauge firstly during injection, and a small amount of air in the liquid injection pipe can smoothly permeate the waterproof breathable film to avoid entering the tumor cavity;
(4) the utility model discloses a setting of No. two three-way pipes can make syringe and No. two syringes inject alone respectively to can not appear the palirrhea condition of medicine when the injection, cause loss of pressure and cause the inaccurate condition of measurement to appear when avoiding truning into the injection medicine by injection normal saline.
Drawings
In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required to be used in the embodiments will be briefly described below, and it is obvious that the drawings in the following description are only some embodiments of the present invention, and for those skilled in the art, other drawings can be obtained according to these drawings without inventive labor.
FIG. 1 is a schematic view of the structure of the device of the present invention;
wherein, 1, a pressure gauge; 2. a waterproof breathable film; 3. a first three-way pipe; 4. scalp acupuncture; 5. a syringe I; 6. a second three-way pipe; 7. and a second syringe.
Detailed Description
The technical solutions in the embodiments of the present invention will be described clearly and completely with reference to the accompanying drawings in the embodiments of the present invention, and it is obvious that the described embodiments are only some embodiments of the present invention, not all embodiments. Based on the embodiments in the present invention, all other embodiments obtained by a person skilled in the art without creative work belong to the protection scope of the present invention.
The utility model aims at providing a device that is used for objective ration injection medicine dose treatment lymphatic vessel deformity to solve the problem that prior art exists, be provided with waterproof ventilated membrane on annotating the pipeline of liquid union coupling manometer, can prevent the medicine flow direction manometer, and can rely on the elasticity that waterproof ventilated membrane itself has to realize the pressure intercommunication of its both sides, thereby can be on the basis that shows injection pressure, avoid the medicine to get into the inaccurate or drug contamination of measurement that the medicine loss that the manometer caused.
In order to make the above objects, features and advantages of the present invention more comprehensible, the present invention is described in detail with reference to the accompanying drawings and the detailed description.
As shown in fig. 1, the utility model provides a device for objectively and quantitatively injecting a drug dose to treat lymphatic malformation, which comprises an injection tube, a syringe 5 connected to the injection end of the injection tube, and a scalp acupuncture 4 connected to the liquid outlet end of the injection tube, wherein the injection tube can be made of latex material, PVC material or TPE material, and is generally a hose, and the length of the injection tube can be reasonably set according to clinical conditions; the first injector 5 is a common structure with a piston, a push rod and a needle tube, and the liquid outlet end of the first injector 5 is communicated with the liquid injection end of the liquid injection tube; the scalp needle 4 can pierce the lymphatic vessel deformity and enter the tumor cavity of the lymphatic vessel deformity, so that the medicine can enter the tumor cavity after passing through the liquid injection tube and the scalp needle 4 under the action of the first injector 5; the liquid injection pipe is connected with a branch pipe, the branch pipe can be a branch pipe directly separated from the liquid injection pipe, for example, a through hole is arranged on the injection pipe, the end part of the branch pipe is connected with the through hole to form connection, or the branch pipe and the liquid injection pipe are integrally formed, in addition, the branch pipe can also be connected with the liquid injection pipe through a three-way pipe, and the branch pipe and the liquid injection pipe can be pipelines made of the same material and have the same size and specification; the first branch pipe is connected with a pressure gauge 1, so that the first injector 5, the pressure gauge 1 and the scalp needle 4 can be mutually communicated, the pressure in the tumor cavity can be displayed by the pressure gauge 1, the pressure can be displayed as P0 after physiological saline washing is carried out on the tumor cavity, the pressure is displayed as P1 after medicine is injected, the difference between the pressure and the pressure is utilized to obtain delta P, and the medicine injected into each tumor cavity can be controlled to be a relative quantitative value by controlling the delta P; the waterproof breathable film 2 is arranged in the radial section of the first branch pipe, the waterproof breathable film 2 can be directly arranged in the first branch pipe, for example, the first branch pipe is disconnected, the waterproof breathable film 2 is bonded between the disconnected surfaces, and then the two disconnected first branch pipes are bonded, so that the waterproof breathable film 2 seals the channel of the first branch pipe, the medicine cannot enter the pressure gauge 1 through the waterproof breathable film 2, but the gas can pass through, and the pressures on the two sides of the waterproof breathable film 2 can be communicated; the waterproof breathable film 2 can also be connected in the first branch pipe through other structures, for example, two identical pipe joints are adopted, the waterproof breathable film 2 is bonded between the end surfaces of the pipe joints, then the two pipe joints are bonded to form an integral anti-backflow structure, and at the moment, the anti-backflow structure is connected between the first branch pipe and the pressure gauge 1, so that the effects of ventilation and prevention of drug passage and pressure communication can be achieved by using the waterproof breathable film 2; through the setting of waterproof ventilated membrane 2, can avoid the medicine to get into manometer 1 and the measurement that the medicine loss that causes is inaccurate or the medicine pollutes on the basis of showing injection pressure (or tumor chamber pressure).
Preferably, the first branch pipe is disconnected into two sections, the middle of the first branch pipe is connected through the pipe joints which are arranged oppositely, the waterproof breathable film 2 is bonded between the two pipe joints, the other end of each pipe joint is connected with the disconnected first branch pipe, the pipe joints can adopt two-way pipe joints or three-way pipe joints, the three-way pipe joints are medical common structures, materials are easy to obtain, the three-way pipe joints can be adopted, and it needs to be stated that when the three-way pipe joints are used, one communicating port in the three-way pipe joints needs to be closed.
The waterproof breathable film 2 can be an e-PTFE film, expanded polytetrafluoroethylene (Expamded PTFE) is abbreviated as e-PTFE, dispersed PTFE resin is expanded into a porous, low-density and high-toughness material through a certain production and processing technology, the material has good air permeability, hydrophobicity and excellent flexibility, and can be applied to a branch pipe I, a medicine can not enter the pressure gauge 1 through the e-PTFE film, but gas can pass through the e-PTFE film, and the pressure on the two sides of the e-PTFE film can be communicated.
Be provided with No. one three-way pipe 3 on the notes liquid pipe, No. one three-way pipe 3 adopts the tee bend coupling commonly used in medical field, and No. one bleeder pipe, syringe 5 and scalp acupuncture 4 are communicate respectively to No. one three-way pipe 3's three intercommunication mouth, and No. one three-way pipe 3's setting for annotate the liquid pipe and can adopt conventional notes liquid pipe, need not with bleeder pipe integrated into one piece, can simplify the forming process who annotates liquid pipe and bleeder pipe.
A three-way pipe 3 can adopt the tee bend pipe, and the tee bend pipe includes that one is responsible for and the branch pipe of perpendicular connection on being responsible for, can connect the both ends that the tee bend pipe was responsible for respectively with syringe 5 and manometer 1 to can make medicine or normal saline directly flow to manometer 1 earlier when the injection, can will annotate the intraductal a small amount of air of liquid and permeate through waterproof ventilated membrane 2 smoothly, and avoid getting into the tumor intracavity.
Can be provided with No. two bleeder on the pipeline between syringe 5 and a three-way pipe 3, No. two bleeder are connected with syringe 7 No. two, can utilize syringe 5 and No. two syringe 7 to inject normal saline and treatment respectively and use the medicine, can make syringe 5 and No. two syringe 7 inject alone respectively, need not change the syringe and can accomplish the injection to normal saline and treatment with the medicine, the palirrhea condition of medicine can not appear when the injection, can avoid causing loss of pressure and cause the inaccurate condition of measurement to appear when trunning into the injection medicine by injecting normal saline.
No. two three-way pipes 6 can be arranged between the first injector 5 and the first three-way pipe 3, the second three-way pipe 6 is a three-way pipe joint commonly used in the medical field, three communicating ports of the second three-way pipe 6 are respectively communicated with the second branch pipe, the second injector 7 and the first three-way pipe 3, the second three-way pipe 6 is arranged, the liquid injection pipe between the first injector 5 and the first three-way pipe 3 can be made to be a conventional liquid injection pipe, the integral forming with the second branch pipe is not needed, and the forming process of the liquid injection pipe and the second branch pipe can be simplified.
Further, a check valve can be arranged between the first injector 5 and the first three-way pipe 3, a check valve can be arranged between the second injector 7 and the second three-way pipe 6, the first check valve and the second check valve can adopt a structure which is supported by the valve clack and the liquid injection pipe in an integrated mode, and can also adopt an independent valve body structure, so that the physiological saline or the medicine can not flow back into the first injector 5 or the second injector 7 after injection.
The utility model discloses an operating procedure when the device that is used for objective ration injection medicine dosage treatment lymphatic vessel deformity specifically uses as follows:
(1) after a scalp needle 4 is pricked into a tumor cavity of a lymphatic malformation (lymphangioma), a first injector 5 (or a second injector 7) is used for injecting normal saline to flush the tumor cavity, the normal saline is reinjected or pumped to control the liquid volume in the tumor cavity, the pressure of the tumor cavity is read by a pressure gauge 1, and the tumor cavity is filled with the normal saline in the cleaning process of injecting the normal saline into the tumor cavity, so that the pressure of the tumor cavity is P0;
(2) inject the medicine through syringe 7 No. two (or syringe 5), read the tumor chamber pressure through manometer 1, it is different according to the tumor chamber size, the injection medicine dosage is also different, this process can produce the pressure after the injection medicine, make tumor chamber pressure be P1, control injection medicine front and back tumor chamber pressure difference Δ P (P1-P0) be a definite value, this just can guarantee the tumor body of equidimension not to a certain extent, the medicine dosage of same volume, pressure has been given, namely through controlling Δ P, make every tumor chamber injection medicine be relative quantitative value.
The utility model discloses a concrete example is applied to explain the principle and the implementation mode of the utility model, and the explanation of the above example is only used to help understand the method and the core idea of the utility model; meanwhile, for the general technical personnel in the field, according to the idea of the present invention, there are changes in the concrete implementation and the application scope. In summary, the content of the present specification should not be construed as a limitation of the present invention.

Claims (8)

1. A device for objective dosing of a drug for treatment of lymphatic malformations, characterized by: including annotating the liquid pipe, connecting annotate the liquid pipe and annotate a syringe of liquid end and connect annotate the liquid pipe and go out the scalp acupuncture of liquid end, annotate and be connected with a bleeder on the liquid pipe, a bleeder is connected with the manometer, be provided with waterproof ventilated membrane in the radial cross-section of bleeder, waterproof ventilated membrane can block the medicine circulation, just waterproof ventilated membrane has elasticity, can receive the pressure after the drum to the opposite side realization pressure transfer in one side.
2. The device for objective quantitative injection of a pharmaceutical dose for treatment of lymphatic malformations according to claim 1, characterized in that: the first branch pipe comprises two pipe joints which are arranged oppositely, and the waterproof breathable film is arranged between the two pipe joints.
3. The device for objective quantitative injection of a pharmaceutical dose for the treatment of lymphatic malformations according to claim 1 or 2, characterized in that: the waterproof breathable film is an e-PTFE film.
4. The device for objective quantitative injection of a drug dose for treatment of lymphatic malformations according to claim 3, characterized in that: the liquid injection pipe is provided with a first three-way pipe, and the first three-way pipe is connected with the first branch pipe.
5. The device for objective quantitative injection of a drug dose for treatment of lymphatic malformations according to claim 4, characterized in that: the first three-way pipe is a regular three-way pipe, and the injector and the pressure gauge are respectively connected to two ends of a main pipe of the regular three-way pipe.
6. The device for objective quantitative injection of a drug dose for treatment of lymphatic malformations according to claim 4, characterized in that: and a second branch pipe is arranged on a pipeline between the first injector and the first three-way pipe, and the second branch pipe is connected with the second injector.
7. The device for objective quantitative injection of a drug dose for treatment of lymphatic malformations according to claim 6, characterized in that: a second three-way pipe is arranged between the first injector and the first three-way pipe, and the second three-way pipe is connected with the second branch pipe.
8. The device for objective quantitative injection of a drug dose for treatment of lymphatic malformations according to claim 7, characterized in that: a first check valve is arranged between the first injector and the first three-way pipe, and a second check valve is arranged between the second injector and the second three-way pipe.
CN202120186479.8U 2021-01-22 2021-01-22 Device for treating lymphatic vessel deformity by objectively and quantitatively injecting medicine dose Active CN214966371U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202120186479.8U CN214966371U (en) 2021-01-22 2021-01-22 Device for treating lymphatic vessel deformity by objectively and quantitatively injecting medicine dose

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202120186479.8U CN214966371U (en) 2021-01-22 2021-01-22 Device for treating lymphatic vessel deformity by objectively and quantitatively injecting medicine dose

Publications (1)

Publication Number Publication Date
CN214966371U true CN214966371U (en) 2021-12-03

Family

ID=79143651

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202120186479.8U Active CN214966371U (en) 2021-01-22 2021-01-22 Device for treating lymphatic vessel deformity by objectively and quantitatively injecting medicine dose

Country Status (1)

Country Link
CN (1) CN214966371U (en)

Similar Documents

Publication Publication Date Title
CN105073003B (en) Pressure-measuring system
WO2015010222A1 (en) Self-sealing anti-thrombotic venous indwelling needle and use method thereof
CN204543206U (en) A kind of Anesthesia Department injection device
CN101829388A (en) Negative pressure closed drainage device
CN201263811Y (en) Positive-pressure joint for infusion without needle
CN206473617U (en) Improved intravenous tube group for embedded catheters irrigation
CN214966371U (en) Device for treating lymphatic vessel deformity by objectively and quantitatively injecting medicine dose
CN102188761A (en) Positive-pressure pinch valve
CN211068264U (en) Improved closed thoracic drainage tube
CN203556057U (en) Junction valve capable of preventing blood return
CN209809178U (en) Medical infusion pipeline
CN203370153U (en) Anti-reflux venous indwelling needle
CN213963520U (en) Soft valve type rapid perfusion system for detecting balloon pressure in real time
CN109172936A (en) A kind of portable infusion apparatus
CN206026750U (en) Multi -functional medical negative pressure drainage device
CN108785775A (en) A kind of ascites drainage retracting device
CN207186866U (en) A kind of Nephrology dept.'s dialysis apparatus
CN209074758U (en) A kind of ear-nose-throat department nasal cavity sponge strip
CN107441586A (en) A kind of portable transfusion auxiliary device
CN209475375U (en) Cuff type soak therapeutic device
CN203898899U (en) Catheter for preventing and treating air embolism
CN106730286A (en) A kind of anorectum department Postoperative Analgesia After hemostasis device
CN213722221U (en) Connecting assembly for assembling uterine cavity water bag
CN206239790U (en) A kind of two-way empty needle
CN205434557U (en) Medical transfusion system

Legal Events

Date Code Title Description
GR01 Patent grant
GR01 Patent grant